(Reuters) White Tale Holdings, the activist investor that thwarted a $20 billion merger between Clariant and U.S. rival Huntsman, on Monday demanded three seats on the Swiss chemical maker’s board and an independent strategic review of the business. The companies dropped their merger plans on Friday after White Tale, an investment vehicle backed by hedge fund manager Keith Meister and New York-based fund 40 North, raised its Clariant stake to more than 20 percent.
Activist White Tale Demands Clariant Board Seats, Review
This entry was posted in Syndicated. Bookmark the permalink.
